Ovid Therapeutics Inc (NASDAQ:OVID)

3.27
Delayed Data
As of 12:58pm ET
 -0.05 / -1.51%
Today’s Change
2.25
Today|||52-Week Range
6.98
+41.56%
Year-to-Date

Stock Price Forecast

The 3 analysts offering 12-month price forecasts for Ovid Therapeutics Inc have a median target of 4.00, with a high estimate of 7.00 and a low estimate of 4.00. The median estimate represents a +22.32% increase from the last price of 3.27.

Analyst Recommendations

The current consensus among 5 polled investment analysts is to Buy stock in Ovid Therapeutics Inc. This rating has held steady since October, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.17
Sales
$0.00
Reporting Date
Mar 15

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 1.82%
 
 
 
 
 
 
Growthannually 241.91%
 
 
 
 
 
 

Sales

Growthquarterly --
 
 
 
 
 
 
Growthannually 1,551.60%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.